Dr Kneeland Youngblood
CIK 1137820 · last filed 2026-06-12
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
WMG price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
2 FOLSOM ST.
SAN FRANCISCO, CA 94105
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Light & Wonder, Inc. (LNW) Delisted | Director | 28,164 | $90.91 | $2.56M | $0 | 8 | 2025-06-11 |
| CORZZ | Director | 40,004 | $13.41 | $536.5K | $0 | 1 | 2024-02-16 |
| CORZW | Director | 400,038 | $6.75 | $2.70M | $0 | 2 | 2024-01-25 |
| Light & Wonder, Inc. (SGMS) Delisted | Director | 5,948 | $58.07 | $345.4K | $0 | 5 | 2021-06-15 |
| Keenova Therapeutics plc (MNK) Delisted | Director | 0 | $0.34 | $0 | $144.5K | 15 | 2020-11-10 |
| Accel Entertainment, Inc. (ACEL.WS) Delisted | — | — | — | $0 | 1 | 2019-11-22 | |
| GAP INC (GPS) Delisted | Director | 36,499 | $24.55 | $896.1K | $0 | 14 | 2012-05-17 |
| STARWOOD HOTELS & RESORTS WORLDWIDE, LLC (HOT) Delisted | Director | 15,113 | — | — | -$1.60M | 32 | 2012-04-03 |
| WMG | Director | 0 | $31.40 | $0 | -$2.96M | 18 | 2010-10-19 |
Recent Filings · Page 3 of 10
99 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-05-17 | Keenova Therapeutics plc (MNK) Delisted | Mixed | +10,869 | -$129.7K | EDGAR |
| 2018-08-08 | Light & Wonder, Inc. (SGMS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-05-18 | Keenova Therapeutics plc (MNK) Delisted | Grant (A) | +18,947 | $0 | EDGAR |
| 2018-03-05 | Keenova Therapeutics plc (MNK) Delisted | Tax (F) | −2,576 | -$40.4K | EDGAR |
| 2017-11-30 | Keenova Therapeutics plc (MNK) Delisted | Buy (P) | +4,560 | $100.0K | EDGAR |
| 2017-10-03 | Keenova Therapeutics plc (MNK) Delisted | Tax (F) | −476 | -$17.8K | EDGAR |
| 2017-03-14 | — | Disp (D) | — | $0 | |
| 2017-03-03 | Keenova Therapeutics plc (MNK) Delisted | Mixed | +3,437 | -$117.8K | EDGAR |
| 2016-10-04 | Keenova Therapeutics plc (MNK) Delisted | Grant (A) | +1,057 | $0 | EDGAR |
| 2016-07-25 | Keenova Therapeutics plc (MNK) Delisted | Grant (A) | +1,037 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.